[144] Amprius Technologies, Inc. SEC Filing
Amprius Technologies, Inc. (AMPX) submitted a Form 144 notice for a proposed sale of common stock through Morgan Stanley Smith Barney LLC with an approximate aggregate market value of $447,511. The filing lists 65,654 shares to be sold on 08/21/2025 on the NYSE. The securities were reported as acquired on 08/20/2025 upon the release of restricted stock units from the issuer and were indicated as compensation, with 126,191 shares shown as the amount acquired. The filing reports 125,075,837 shares outstanding. No sales by the reporting person were reported in the past three months. The filer attests there is no undisclosed material adverse information.
Amprius Technologies, Inc. (AMPX) ha presentato un avviso Form 144 per una proposta vendita di azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di circa $447.511. La comunicazione indica la vendita di 65.654 azioni prevista per il 21/08/2025 sul NYSE. I titoli risultano acquisiti il 20/08/2025 in seguito al rilascio di restricted stock unit dall’emittente e sono stati indicati come compenso, con 126.191 azioni segnalate come importo acquisito. Il filing riporta 125.075.837 azioni in circolazione. Negli ultimi tre mesi non risultano vendite effettuate dalla persona che effettua la segnalazione. Il dichiarante conferma che non ci sono informazioni rilevanti negative non divulgate.
Amprius Technologies, Inc. (AMPX) presentó un aviso Form 144 para la posible venta de acciones ordinarias a través de Morgan Stanley Smith Barney LLC por un valor de mercado aproximado de $447,511. El documento indica la venta de 65,654 acciones programada para el 21/08/2025 en la NYSE. Los valores se notificaron como adquiridos el 20/08/2025 tras la liberación de restricted stock units por parte del emisor y se señalaron como compensación, mostrando 126,191 acciones adquiridas. El filing reporta 125,075,837 acciones en circulación. No se informaron ventas por parte del declarante en los últimos tres meses. El presentador afirma que no existe información adversa material no divulgada.
Amprius Technologies, Inc. (AMPX)는 Morgan Stanley Smith Barney LLC를 통해 보통주 매각을 제안하는 Form 144 통지를 제출했으며, 총 시장 가치는 약 $447,511입니다. 신고서에는 65,654주를 2025-08-21 NYSE에서 매각할 예정이라고 기재되어 있습니다. 해당 증권은 발행인의 restricted stock units 해제에 따라 2025-08-20에 취득된 것으로 보고되었고 보상으로 표시되었으며, 취득액은 126,191주로 기재되어 있습니다. 총 발행주식수는 125,075,837주로 보고되었습니다. 신고인은 최근 3개월 내에 매각한 내역이 없다고 보고했습니다. 제출자는 미공개의 중대한 불리한 정보가 없음을 확인합니다.
Amprius Technologies, Inc. (AMPX) a déposé un avis Form 144 pour une proposition de vente d’actions ordinaires via Morgan Stanley Smith Barney LLC, pour une valeur de marché totale d’environ $447,511. Le dossier indique la vente de 65,654 actions prévue le 21/08/2025 à la NYSE. Les titres ont été déclarés acquis le 20/08/2025 suite à la libération de restricted stock units par l’émetteur et ont été indiqués comme une rémunération, 126,191 actions étant mentionnées comme montant acquis. Le dépôt fait état de 125,075,837 actions en circulation. Aucune vente de la personne déclarant n’a été signalée au cours des trois derniers mois. Le déclarant atteste qu’il n’existe aucune information défavorable importante non divulguée.
Amprius Technologies, Inc. (AMPX) reichte eine Form-144-Mitteilung für einen geplanten Verkauf von Stammaktien über Morgan Stanley Smith Barney LLC mit einem ungefähren Marktwert von $447.511 ein. Die Meldung weist 65.654 zum Verkauf stehende Aktien am 21.08.2025 an der NYSE aus. Die Wertpapiere wurden am 20.08.2025 als erworben gemeldet, infolge der Freigabe von Restricted Stock Units durch den Emittenten, und als Vergütung angegeben; als erworbene Menge sind 126.191 Aktien aufgeführt. In der Einreichung werden 125.075.837 ausstehende Aktien angegeben. In den letzten drei Monaten wurden keine Verkäufe durch die meldende Person berichtet. Der Einreicher versichert, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.
- Broker and market specified: Sale to be executed through Morgan Stanley Smith Barney LLC on the NYSE, providing clear execution channel.
- Acquisition clearly disclosed: Shares were acquired by release of restricted stock units and recorded as compensation.
- None.
Insights
TL;DR: Routine insider sale notice: newly vested RSUs being sold through a broker, no prior sales reported in the last three months.
The Form 144 documents a proposed sale of 65,654 common shares via Morgan Stanley Smith Barney with an aggregate market value of $447,511, to occur on 08/21/2025. The shares were acquired on 08/20/2025 through release of restricted stock units and are labeled as compensation. The filing discloses 125,075,837 shares outstanding and states there were no securities sold in the past three months by the reporting person. This is a standard Form 144 disclosure required for certain insider sales and contains no additional commentary or indications of undisclosed material events.
TL;DR: Compliance-focused filing showing issuance and planned sale of vested RSUs; conforms to Rule 144 requirements.
The notice identifies the broker, the class of securities, the number of shares to be sold, and the method of acquisition (release of restricted stock units) with payment characterized as compensation. The signer affirms lack of material non-public information. There are no disclosures of prior sales within the trailing three-month period. From a governance and disclosure perspective, the form contains the elements expected for an insider sale under Rule 144.
Amprius Technologies, Inc. (AMPX) ha presentato un avviso Form 144 per una proposta vendita di azioni ordinarie tramite Morgan Stanley Smith Barney LLC, per un valore di mercato complessivo di circa $447.511. La comunicazione indica la vendita di 65.654 azioni prevista per il 21/08/2025 sul NYSE. I titoli risultano acquisiti il 20/08/2025 in seguito al rilascio di restricted stock unit dall’emittente e sono stati indicati come compenso, con 126.191 azioni segnalate come importo acquisito. Il filing riporta 125.075.837 azioni in circolazione. Negli ultimi tre mesi non risultano vendite effettuate dalla persona che effettua la segnalazione. Il dichiarante conferma che non ci sono informazioni rilevanti negative non divulgate.
Amprius Technologies, Inc. (AMPX) presentó un aviso Form 144 para la posible venta de acciones ordinarias a través de Morgan Stanley Smith Barney LLC por un valor de mercado aproximado de $447,511. El documento indica la venta de 65,654 acciones programada para el 21/08/2025 en la NYSE. Los valores se notificaron como adquiridos el 20/08/2025 tras la liberación de restricted stock units por parte del emisor y se señalaron como compensación, mostrando 126,191 acciones adquiridas. El filing reporta 125,075,837 acciones en circulación. No se informaron ventas por parte del declarante en los últimos tres meses. El presentador afirma que no existe información adversa material no divulgada.
Amprius Technologies, Inc. (AMPX)는 Morgan Stanley Smith Barney LLC를 통해 보통주 매각을 제안하는 Form 144 통지를 제출했으며, 총 시장 가치는 약 $447,511입니다. 신고서에는 65,654주를 2025-08-21 NYSE에서 매각할 예정이라고 기재되어 있습니다. 해당 증권은 발행인의 restricted stock units 해제에 따라 2025-08-20에 취득된 것으로 보고되었고 보상으로 표시되었으며, 취득액은 126,191주로 기재되어 있습니다. 총 발행주식수는 125,075,837주로 보고되었습니다. 신고인은 최근 3개월 내에 매각한 내역이 없다고 보고했습니다. 제출자는 미공개의 중대한 불리한 정보가 없음을 확인합니다.
Amprius Technologies, Inc. (AMPX) a déposé un avis Form 144 pour une proposition de vente d’actions ordinaires via Morgan Stanley Smith Barney LLC, pour une valeur de marché totale d’environ $447,511. Le dossier indique la vente de 65,654 actions prévue le 21/08/2025 à la NYSE. Les titres ont été déclarés acquis le 20/08/2025 suite à la libération de restricted stock units par l’émetteur et ont été indiqués comme une rémunération, 126,191 actions étant mentionnées comme montant acquis. Le dépôt fait état de 125,075,837 actions en circulation. Aucune vente de la personne déclarant n’a été signalée au cours des trois derniers mois. Le déclarant atteste qu’il n’existe aucune information défavorable importante non divulguée.
Amprius Technologies, Inc. (AMPX) reichte eine Form-144-Mitteilung für einen geplanten Verkauf von Stammaktien über Morgan Stanley Smith Barney LLC mit einem ungefähren Marktwert von $447.511 ein. Die Meldung weist 65.654 zum Verkauf stehende Aktien am 21.08.2025 an der NYSE aus. Die Wertpapiere wurden am 20.08.2025 als erworben gemeldet, infolge der Freigabe von Restricted Stock Units durch den Emittenten, und als Vergütung angegeben; als erworbene Menge sind 126.191 Aktien aufgeführt. In der Einreichung werden 125.075.837 ausstehende Aktien angegeben. In den letzten drei Monaten wurden keine Verkäufe durch die meldende Person berichtet. Der Einreicher versichert, dass keine nicht offengelegten wesentlichen nachteiligen Informationen vorliegen.